Want To Avoid A Refuse-To-File? Submit ANDA In English, FDA Says

Generic applications continue to be tripped up by failing to adhere to other well-known standards such as paying user fees, US agency says.

RulesRegulationsBooks_1200x675

More from Generics

More from Biosimilars & Generics